Article

New Products & Services

Irvine, CA-The Cryocare CN2 System from Endocare, Inc. has received 510K clearance from the FDA. The device uses the freezing capability of nitrogen at the point between gas and liquid-"critical nitrogen"-to destroy cancerous tissue quicker and more cost-effectively than argon can, according to the manufacturer. The speed and precision of this new technology can expedite procedures, Endocare says, because it is easy to use and it delivers a colder, more powerful ice ball at the end of the probes.

Related Videos
Petar Bajic, MD, answers a question during a video interview
Ellen Cahill, MD, answers a question during a video interview
1 KOL is featured in this series.
1 KOL is featured in this series.
Raevti Bole, MD, answers a question during a video interview
Denise Asafu-Adjei, MD, MPH, answers a question during a video interview
Amy Pearlman, MD, answers a question during a video interview
Related Content
Sacituzumab govitecan withdrawn from bladder cancer market following negative trial
October 21st 2024

Sacituzumab govitecan withdrawn from bladder cancer market following negative trial

Hannah Clarke
The decision to withdraw sacituzumab govitecan from the market was made in consultation with the US FDA following negative data from the phase 3 TROPiCS-04 trial.
Key updates from the AUA/ASRM male infertility guideline amendment
September 23rd 2024

Key updates from the AUA/ASRM male infertility guideline amendment

Urology Times staff
In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility.
Low-intensity shockwave therapy, plasma injections efficacious for erectile dysfunction
October 20th 2024

Low-intensity shockwave therapy, plasma injections efficacious for erectile dysfunction

Kevin Kunzmann
SMSNA 2024 abstract data show shockwave therapies and platelet-rich plasma, either alone or in combination, may be promising treatments for ED.
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
July 24th 2024

Speaking of Urology: Dr. Winter on the use of vaginal estrogen

Urology Times staff
In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
October 19th 2024

Satisfaction compared for IPP reservoir placement in prevesical vs ectopic location

Benjamin P. Saylor
“The take-home message…is it doesn't matter whether you put the reservoir in the ectopic location or the prevesical location. Patients tend to be satisfied in both locations,” said Mohit Khera, MD, MBA, MPH.
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
October 19th 2024

BPH is linked with erectile dysfunction in US men

Benjamin P. Saylor
The investigators reported a significantly greater prevalence of ED in men with BPH (P < .0001).
© 2024 MJH Life Sciences

All rights reserved.